Menu Back to Poster-Presentations-Details
W 04: A Value-Driven Decision Making for Drug Development Strategy
- Director, Advanced Informatics and Analytics
- Astellas Pharma Inc.
Patel et al. (2013) proposed the value-driven framework to optimize sample sizes and trial schedules for Phase III. I propose to optimize the whole development program in one compound by minimizing the risk and maximizing the eNPV from much more macro viewpoint.